Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Plexus Corp’s disclosures can feel like assembling a multilayer circuit board—every footnote, customer-concentration table, and segment margin matters. Yet the company’s 10-K often exceeds 250 pages and its 8-K material events arrive without notice.
Stock Titan eliminates the guesswork. Our AI parses each Plexus SEC filing the moment it hits EDGAR, then delivers plain-English highlights so you can:
- See Plexus insider trading Form 4 transactions and receive Plexus Form 4 insider transactions real-time alerts.
- Compare backlog trends inside the Plexus quarterly earnings report 10-Q filing.
- Review supply-chain risk updates with our Plexus 8-K material events explained summaries.
Need to understand cost-plus defense contracts or how healthcare orders affect margins? Our AI-powered summaries point you straight to the notes that matter, making Plexus SEC filings explained simply.
For deeper dives, open the original documents beside concise annotations: the Plexus annual report 10-K simplified section decodes multi-segment revenue, while our proxy overview answers your search for Plexus proxy statement executive compensation. Investors tracking leadership moves can monitor Plexus executive stock transactions Form 4 without scanning dozens of PDFs.
Whether you’re researching contract manufacturing exposure or seeking a quick Plexus earnings report filing analysis, Stock Titan’s real-time data and expert context let you act with clarity, not guesswork.
Plexus Corp. director reports amended stock gift transaction
A Plexus Corp. (PLXS) director reported the bona fide gift of 700 shares of Plexus common stock. After this gift, the director beneficially owns 8,165 shares in direct form. This amendment corrects the transaction date to November 21, 2025, clarifying that an earlier attempted transfer on November 4, 2025 did not go through due to an administrative error and the shares were returned before being successfully transferred on the corrected date.
Plexus Corp. (PLXS) executive Oliver K. Mihm, Exec VP & COO, reported several equity transactions in company stock. On 11/12/2025, 5,023 shares of common stock were acquired following the vesting and settlement of performance stock units, while 2,361 shares were disposed of at a price of $146.24 per share, typically reflecting shares withheld or sold to cover taxes. Mihm also made a bona fide gift of 1,100 shares of Plexus common stock.
The filing shows 981 shares of Plexus common stock held indirectly in the company’s 401(k) Retirement Plan. In addition, 1,383 new performance stock units were credited based on company performance. The company disclosed that 138% of the economic return portion of performance stock units granted in fiscal 2023 vested, while the portion tied to relative total shareholder return versus the S&P 400 Index has not yet completed its three-year performance period.
Plexus Corp. filed its Annual Report (10-K) for the fiscal year ended September 27, 2025. The company designs, manufactures and services highly complex products across Aerospace/Defense, Healthcare/Life Sciences, and Industrial markets, operating 26 facilities with a global team of over 20,000. Management targets long-term compounded annual revenue growth of 9–12% and a 15% ROIC; Plexus’ internal WACC for fiscal 2025 was 8.9%.
Customer exposure is diversified: approximately 190 customers in fiscal 2025 and no single customer over 10% of sales. Net sales mix in 2025 was 17% Aerospace/Defense, 40% Healthcare/Life Sciences, and 43% Industrial. Shares outstanding were 27,121,994 as of March 29, 2025; as of November 10, 2025, there were 26,774,415 shares outstanding. The company highlights robust certifications (including ISO and FDA-related capabilities) and details risk factors such as supply chain constraints, regulatory complexity, competition, and geopolitical volatility.
Plexus Corp (PLXS) Executive VP & CFO reported insider transactions. On 11/11/2025, he sold 2,000 shares of common stock at $143.535. On 11/12/2025, 6,458 Performance Stock Units (PSUs) were converted to common stock (code M), and 3,036 shares were withheld to cover taxes at $146.24 (code F).
After these transactions, he held 20,383 shares directly and 3,719 shares in the company 401(k). The filing notes that, based on company performance for economic return goals over three years, 138% of the fiscal 2023 PSU tranche vested; the relative TSR portion’s performance period has not concluded.
Plexus Corp (PLXS) reported an insider transaction by its Exec VP, CAO, General Counsel & Secretary. On 11/10/2025, the officer sold 2,500 shares of common stock, coded “S” for sale, at a weighted average price of $145.2771. Following the sale, the reporting person beneficially owns 20,895 shares, held directly.
The filing notes the sale was executed in multiple trades within a price range of $145.0001 to $145.56 per share, with the weighted average reported. This is a routine Form 4 disclosure of insider activity and does not alter the company’s capital structure.
Plexus Corp. (PLXS) director reported a personal stock transaction. On 11/04/2025, the reporting person made a bona fide gift of 700 shares of Plexus common stock, coded “G.” After this transaction, the reporting person beneficially owns 8,165 shares, held directly.
This filing reflects a charitable or personal transfer and does not indicate a sale for proceeds.
Plexus Corp (PLXS) President & CEO and director Todd P. Kelsey reported open‑market sales of common stock on 11/03/2025, 11/04/2025, and 11/05/2025 pursuant to a Rule 10b5‑1 plan adopted on August 16, 2024. He sold 1,500 shares at $139.12, 2,000 shares at $143.50, and 2,000 shares at $145.10. After these transactions, he beneficially owned 58,714 shares, held directly.
Plexus Corp (PLXS) reported an amended insider filing. A company director filed a Form 4/A to correct the reported equity award to 1,370 Restricted Stock Units granted on 02/03/2025. Each RSU represents a right to receive one share of Plexus common stock under the 2024 Omnibus Incentive Plan. The RSUs vest on February 3, 2026, and the filing lists direct ownership. The amendment states it was filed to correct the number of RSUs granted.
Plexus Corp (PLXS) reported an insider update. Director Michael V. Schrock filed a Form 4/A amending a prior report to reflect the acquisition of 1,370 restricted stock units on February 3, 2025 under the Plexus Corp. 2024 Omnibus Incentive Plan.
Each RSU represents the right to receive one share of Plexus common stock. The RSUs vest on February 3, 2026. The amendment states it was filed to correct the number of Restricted Stock Units granted.
Plexus Corp (PLXS) reported an amended insider filing. A company director filed a Form 4/A to correct the size of a previously reported equity award to 1,370 Restricted Stock Units granted on 02/03/2025 under the Plexus Corp. 2024 Omnibus Incentive Plan, reported with transaction code A.
Each RSU represents a contingent right to receive one share of Plexus common stock and vests on 02/03/2026. Following the transaction, 1,370 derivative securities were beneficially owned directly. The amendment notes the change was made to correct the number of RSUs granted.
FAQ
What is the current stock price of Plexus (PLXS)?
What is the market cap of Plexus (PLXS)?
